Cerebral Metabolic Correlates of the Clinical Dementia Rating Scale in Mild Cognitive Impairment

Abstract

Mild cognitive impairment (MCI) is often a prodromal state of Alzheimer's disease (AD). Imaging studies have shown that metabolic deficits in cerebral regions known to be affected early by AD pathology are predictive of progression to AD. In the present article, the authors examine associations between clinical impairment (Clinical Dementia Rating scale sum of boxes [CDR-SB]) and regional deficits in glucose utilization in a sample of 41 patients with MCI, who underwent cerebral ¹⁸F-FDG PET for the measurement of regional glucose metabolism. A linear regression analysis with CDR-SB score as the independent variable and glucose metabolism as the dependent variable, adjusted for age, gender, and years of school education, was conducted in voxel-by-voxel fashion in SPM2. The regression analysis revealed a significant negative association between CDR-SB score and glucose metabolism in the right posterior cingulate gyrus (P < .001, uncorrected for multiple comparisons), which was independent from demographical variables. The authors conclude that clinical severity of impairments is already correlated with deficits in glucose metabolism in the stage of MCI. (J Geriatr Psychiatry Neurol 2007;20:84-88)

Keywords

clinical dementia rating positron emission tomography cerebral glucose metabolism mild cognitive impairment Alzheimer's disease dementia

References

Petersen RC , Doody R. , Kurz A. , et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985-1992.

Morris JC , Storandt M. , Miller JP , et al. Mild cognitive impairment represents early-stage Alzheimer disease . Arch Neurol. 2001;58:397-405.

Grundmann M. , Petersen R. , Morris J. , et al. Rate of dementia of the Alzheimer type (DAT) in subjects with mild cognitive impairment. Neurology. 1996;46:A403.

Petersen RC , Smith GE , Waring SC , et al. Mild cognitive impairment: clinical characterization and outcome . Arch Neurol. 1999;56:303-308.

Kurz A. , Diehl J. , Riemenschneider M. , et al. Mild cognitive disorder. Questions of definition, diagnosis, prognosis and therapy. Nervenarzt. 2004;75:6-15.

Alexopoulos P. , Grimmer T. , Perneczky R. , Domes G. Progression to dementia in clinical subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord. 2006;22:27-34.

Lautenschlager N. , Drzezga A. , Kurz A. Metabolism in cognitive impairment. A PET study. Aust N Z J Psychiatry. 2001; 35:A17.

Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann Nucl Med. 2001;15:85-92.

Wolf H. , Jelic V. , Gertz H. , et al. A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol Scand. 2003;107:52-76.

10.

Lautenschlager NT , Riemenschneider M. , Drzezga A. , Kurz AF Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings. Dement Geriatr Cogn Disord. 2001 ;12:379-386.

11.

Drzezga A. , Lautenschlager N. , Siebner H. , et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging. 2003;30:1104-1113.

12.

Morris J. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412-2414.

13.

Morris J. , McKeel D. , Fulling K. , et al. Validation of clinical diagnostic criteria for Alzheimer's disease . Ann Neurol. 1988; 24:17-22.

14.

Folstein MF , Folstein SE , McHugh PR “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.

15.

Petersen RC , Smith GE , Waring SC , et al. Aging, memory, and mild cognitive impairment. Int Psychogeriatr. 1997;9(Suppl 1): 65-69.

16.

McKhann G. , Folstein M. , Katzman R. , et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 ;34:939-944.

17.

Drzezga A. , Riemenschneider M. , Strassner B. , et al. Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology. 2005;64:102-107.

18.

Drzezga A. , Darsow U. , Treede RD , et al. Central activation by histamine-induced itch: analogies to pain processing: a correlational analysis of O-15 H2O positron emission tomography studies. Pain. 2001;92:295-305.

19.

Talairach J. , Tournoux P. Co-Planar Stereotactical Atlas of the Human Brain: 3-Dimensional Proportional System—An Approach to Cerebral Imaging. New York : Thieme Medical; 1988.

20.

Perneczky R. , Wagenpfeil S. , Komossa K. , et al. Mapping scores onto stages: Mini-Mental-State Examination and Clinical Dementia Rating. Am J Geriatr Psychiatry . 2006;14:139-144.

21.

Petersen RC , Thomas RG , Grundman M. , et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352:2379-2388.

22.

Geslani DM , Tierney MC , Herrmann N. , Szalai JP Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease. Dement Geriatr Cogn Disord. 2005;19:383-389.

23.

Galvin J. , Kimberley K. , Powlishta K. , et al. Predictors of pre-clinical Alzheimer disease and dementia. Arch Neurol. 2005; 62:758-765.